Mechanisms of Action of Eg5 Inhibitors

  • Robert A. CrossEmail author


Many inhibitors have now been described that bind specifically to Eg5. It is clear that inhibition is allosteric and that the binding of inhibitors influences motor activity largely by influencing the dynamics of nucleotide exchange, but surprisingly, whilst the residue requirements in the motor and the structure-activity relationships for the inhibitors have been examined by several groups, the allosteric molecular mechanisms by which inhibitors inhibit nucleotide exchange at the active site have not been widely discussed. The conformational cycle of the Eg5 motor is increasingly well understood, and understanding exactly how this cycle is arrested by inhibitors is an important problem. Here I briefly review current evidence on the structural mechanisms by which allosteric Eg5 inhibitors inhibit motor activity. I suggest that current Eg5 inhibitors work predominantly by stabilising the active site Mg2+ ion, and that they do this by stabilising the loop L5 in an apo-like conformation.


Salt Bridge Inhibited State Motor Head Global Conformation Drug Binding Pocket 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Crevel IM-TC, Alonso MC, Cross RA (2004) Monastrol stabilises an attached low-friction mode of Eg5. Curr Biol 14:R411–R412CrossRefPubMedGoogle Scholar
  2. 2.
    Scarabelli G, Grant BJ (2013) Mapping the structural and dynamical features of kinesin motor domains. PLoS Comput Biol 9:e1003329CrossRefPubMedCentralPubMedGoogle Scholar
  3. 3.
    Parke CL, Wojcik EJ, Kim S, Worthylake DK (2010) ATP hydrolysis in Eg5 kinesin involves a catalytic two-water mechanism. J Biol Chem 285:5859–5867CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Onishi H, Mochizuki N, Morales MF (2004) On the myosin catalysis of ATP hydrolysis. Biochemistry 43:3757–3763CrossRefPubMedGoogle Scholar
  5. 5.
    Kull FJ, Endow SA (2013) Force generation by kinesin and myosin cytoskeletal motor proteins. J Cell Sci 126:9–19CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Ma YZ, Taylor EW (1995) Kinetic mechanism of kinesin motor domain. Biochemistry 34:13233–13241CrossRefPubMedGoogle Scholar
  7. 7.
    Vale RD (1996) Switches, latches, and amplifiers: common themes of G proteins and molecular motors. J Cell Biol 135:291–302CrossRefPubMedGoogle Scholar
  8. 8.
    Nitta R, Okada Y, Hirokawa N (2008) Structural model for strain-dependent microtubule activation of Mg-ADP release from kinesin. Nat Struct Mol Biol 15:1067–1075CrossRefPubMedGoogle Scholar
  9. 9.
    Chang Q, Nitta R, Inoue S, Hirokawa N (2013) Structural basis for the ATP-induced Isomerization of Kinesin. J Mol Biol 425:1869–1880. doi: 10.1016/j.jmb.2013.03.004
  10. 10.
    Goulet A, Major J, Jun Y, GROSS SP, Rosenfeld SS, Moores CA (2014) Comprehensive structural model of the mechanochemical cycle of a mitotic motor highlights molecular adaptations in the kinesin family. Proc Natl Acad Sci U S A 111:1837–1842CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Talapatra SK, Anthony NG, Mackay SP, Kozielski F (2013) Mitotic kinesin Eg5 overcomes inhibition to the phase I/II clinical candidate SB743921 by an allosteric resistance mechanism. J Med Chem 56:6317–6329CrossRefPubMedGoogle Scholar
  12. 12.
    Behnke-Parks WM, Vendome J, Honig B, Maliga Z, Moores C, Rosenfeld SS (2011) Loop L5 acts as a conformational latch in the mitotic kinesin Eg5. J Biol Chem 286:5242–5253CrossRefPubMedCentralPubMedGoogle Scholar
  13. 13.
    Harrington TD, Naber N, Larson AG, Cooke R, Rice SE, Pate E (2011) Analysis of the interaction of the Eg5 Loop5 with the nucleotide site. J Theor Biol 289:107–115CrossRefPubMedCentralPubMedGoogle Scholar
  14. 14.
    Cochran JC, Gilbert SP (2005) ATPase mechanism of Eg5 in the absence of microtubules: insight into microtubule activation and allosteric inhibition by monastrol. Biochemistry 44:16633–16648CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Maliga Z, Xing J, Cheung H, Juszczak LJ, Friedman JM, Rosenfeld SS (2006) A pathway of structural changes produced by monastrol binding to Eg5. J Biol Chem 281:7977–7982CrossRefPubMedGoogle Scholar
  16. 16.
    Liu L, Parameswaran S, Liu J, Kim S, Wojcik EJ (2011) Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms. J Biol Chem 286:6201–6210CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Bodey AJ, Kikkawa M, Moores CA (2009) 9-Angström structure of a microtubule-bound mitotic motor. J Mol Biol 388:218–224CrossRefPubMedGoogle Scholar
  18. 18.
    Muretta JM, Behnke-Parks WM, Major J, Petersen KJ, Goulet A, Moores CA, Thomas DD, Rosenfeld SS (2013) Loop L5 assumes three distinct orientations during the ATPase cycle of the mitotic kinesin Eg5: a transient and time-resolved fluorescence study. J Biol Chem 288:34839–34849CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Waitzman JS, Larson AG, Cochran JC, Naber N, Cooke R, Jon Kull F, Pate E, Rice SE (2011) The loop 5 element structurally and kinetically coordinates dimers of the human kinesin-5, Eg5. Biophys J 101:2760–2769CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Waitzman JS, Rice SE (2014) Mechanism and regulation of kinesin-5, an essential motor for the mitotic spindle. Biol Cell 106:1–12. doi: 10.1111/boc.201300054
  21. 21.
    Shipley K, Hekmat-Nejad M, Turner J, Moores C, Anderson R, Milligan R, Sakowicz R, Fletterick R (2004) Structure of a kinesin microtubule depolymerization machine. EMBO J 23:1422–1432CrossRefPubMedCentralPubMedGoogle Scholar
  22. 22.
    Ulaganathan VV, Talapatra SKS, Rath OO, Pannifer AA, Hackney DDD, Kozielski FF (2013) Structural insights into a unique inhibitor binding pocket in kinesin spindle protein. J Am Chem Soc 135:2263–2272CrossRefPubMedGoogle Scholar
  23. 23.
    Groen AC, Needleman D, Brangwynne C, Gradinaru C, Fowler B, Mazitschek R, Mitchison TJ (2008) A novel small-molecule inhibitor reveals a possible role of kinesin-5 in anastral spindle-pole assembly. J Cell Sci 121:2293–2300CrossRefPubMedCentralPubMedGoogle Scholar
  24. 24.
    Tarui Y, Chinen T, Nagumo Y, Motoyama T, Hayashi T, Hirota H, Muroi M, Ishii Y, Kondo H, Osada H, Usui T (2014) Terpendole E and its derivative inhibit STLC- and GSK-1-resistant Eg5. Chembiochem 15:934–938CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  1. 1.Warwick Medical SchoolCoventryUK

Personalised recommendations